Trial By Fire Solutions, a leading eClinical solution provider specializing in clinical study management applications, announced today that a public, multi-national, US-based biopharmaceutical company has selected SimpleCTMS to help manage their portfolio of clinical studies for their growing pipeline of drug candidates that target liver diseases.
This sponsor organization had previously implemented other eClinical systems including an eTMF and IWRS/EDC systems and were looking for an easy to implement, easy to use CTMS system that could be readily accessed by team members in their global offices. Additionally, they had specific needs to integrate with their EDC provider to facilitate the management of investigator payments related to subject visits. Standard study startup planning functionality, site enrollment tracking and out-of-the-box dashboards and reports were also key drivers in the decision to adopt SimpleCTMS for their study teams.
“This client has been great to work with from the start of the engagement.” Said Nancy Cecchettini, Chief Product Officer of Trial By Fire Solutions. “The efforts to integrate with the EDC vendor were efficient and enabled the implementation to occur in a very short period of time. Additionally, their ongoing proactive input and efficient decision making have enabled their study teams to effectively utilize SimpleCTMS for study-specific nuances such as partial payments and detailed startup tracking metrics. We couldn’t be happier to continue our support of such a busy and driven client team!”